Chin-Chou Huang Selected Research

Chin-Chou Huang Research Topics

Disease

14	Hypertension (High Blood Pressure) 01/2022 - 04/2011
11	Coronary Artery Disease (Coronary Atherosclerosis) 10/2021 - 06/2010
9	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 10/2011
9	Heart Failure 01/2022 - 01/2016
8	Myocardial Infarction 01/2022 - 01/2012
7	Ischemic Stroke 01/2022 - 12/2012
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2009
5	Inflammation (Inflammations) 01/2022 - 05/2011
5	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2018
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 12/2011
5	Atrial Fibrillation 12/2020 - 03/2010
4	Stroke (Strokes) 10/2021 - 03/2013
3	Atherosclerosis 12/2022 - 07/2016
3	Diabetes Mellitus 03/2020 - 05/2011
3	Chronic Renal Insufficiency 01/2018 - 05/2011
3	Neoplasms (Cancer) 01/2013 - 04/2011
2	Albuminuria 01/2022 - 06/2020
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2021 - 01/2012
2	Death (Near-Death Experience) 05/2020 - 01/2020
2	Hypercholesterolemia 03/2020 - 07/2014
2	Venous Thrombosis (Deep-Vein Thrombosis) 12/2014 - 10/2013
2	Asthma (Bronchial Asthma) 09/2014 - 05/2011
2	Peptic Ulcer (Peptic Ulcers) 01/2013 - 12/2011
2	Hemorrhage 01/2013 - 12/2011
2	Non-alcoholic Fatty Liver Disease 01/2012 - 12/2010
1	Necrosis 01/2022
1	Hypertensive Nephropathy 01/2022
1	Arteriovenous Fistula 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2022
1	Masked Hypertension 01/2021
1	End Stage Liver Disease 11/2020
1	Macular Degeneration (Age-Related Maculopathy) 03/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2020
1	Homozygous Familial Hypercholesterolemia 01/2019
1	Heart Arrest (Cardiac Arrest) 03/2017
1	Cardiac Arrhythmias (Arrythmia) 01/2017
1	Kidney Diseases (Kidney Disease) 04/2016
1	Isolated Systolic Hypertension 01/2016
1	Cardiomegaly (Heart Hypertrophy) 01/2016
1	Diastolic Heart Failure 01/2016

Drug/Important Bio-Agent (IBA)

7	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2020
5	LipidsIBA 12/2022 - 10/2015
5	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 11/2009
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 05/2011
4	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2022 - 08/2014
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2009
3	LDL CholesterolIBA 12/2022 - 01/2019
3	fibroblast growth factor 21IBA 01/2022 - 01/2016
3	ThiazidesIBA 01/2016 - 01/2013
3	Angiotensin Receptor AntagonistsIBA 08/2015 - 04/2011
2	BilirubinIBA 11/2020 - 07/2016
2	Type I Tumor Necrosis Factor ReceptorsIBA 10/2020 - 06/2020
2	Indicators and Reagents (Reagents)IBA 03/2020 - 12/2012
2	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2016 - 01/2013
2	Insulin (Novolin)FDA Link 12/2014 - 04/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2014 - 09/2014
2	C-Reactive ProteinIBA 05/2013 - 12/2010
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2013 - 01/2013
2	erucylphosphocholineIBA 01/2013 - 01/2012
2	Clopidogrel (Plavix)FDA Link 01/2013 - 06/2010
1	oxidized low density lipoproteinIBA 12/2022
1	NucleotidesIBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	CytokinesIBA 01/2022
1	CholesterolIBA 01/2022
1	Interleukin Receptors (Interleukin Receptor)IBA 01/2022
1	PTX3 proteinIBA 01/2022
1	Lipocalin-2IBA 01/2022
1	Chitinase-3-Like Protein 1IBA 01/2022
1	Member 3 Solute Carrier Family 12IBA 01/2022
1	CalciumIBA 01/2022
1	Nifedipine (Adalat)FDA LinkGeneric 01/2022
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2022
1	Phosphates (Orthophosphate)IBA 10/2021
1	AlbuminsIBA 11/2020
1	Antihypertensive Agents (Antihypertensives)IBA 11/2020
1	Ether (Diethyl Ether)IBA 06/2020
1	MelatoninIBA 03/2020
1	Arachidonic Acid (Vitamin F)IBA 01/2020
1	OxylipinsIBA 01/2020
1	Uric Acid (Urate)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	Proprotein Convertase 9IBA 01/2019
1	evolocumabIBA 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2017
1	AntioxidantsIBA 07/2016
1	Nicotinamide PhosphoribosyltransferaseIBA 04/2016
1	LigandsIBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2013
6	Percutaneous Coronary Intervention 10/2021 - 06/2010
2	Renal Dialysis (Hemodialysis) 01/2022 - 12/2011
2	Catheter Ablation 02/2013 - 03/2010
1	Ambulatory Care (Outpatient Care) 01/2021
1	Peritoneal Dialysis 12/2020
1	Cardiopulmonary Resuscitation (CPR) 03/2017
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2017
1	Aftercare (After-Treatment) 01/2016